🟠 #Alyftrek demonstrated safety and tolerability, with 96% of participants reporting mild or moderate adverse events and 8% experiencing serious adverse events, including exacerbations and infections. #CRISPR #biotech $VRTX $NTLA $PRME $EDIT @FDA